Curis | CRIS - Assets


Curis reported $29.23M in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Amgen USD 90.59B 445M Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
CSL USD 37.9B 1.5B Dec/2025
Curis USD 29.23M 10.09M Jun/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Exelixis USD 2.84B 20.87M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Takeda JPY 15.41T 938.47B Dec/2025
TG Therapeutics USD 1.06B 38.23M Dec/2025
Verastem USD 176.85M 45.15M Sep/2025
Xoma USD 263.15M 39.7M Sep/2025